Cargando…
An antibiotic’s journey from marketing authorization to use, Norway
Here we describe in detail marketing authorization and reimbursement procedures for medicinal products in Norway, with particular reference to nine novel antibiotics that received marketing authorization between 2005 and 2015. The description illustrates that, in places like Norway, with effective a...
Autores principales: | Årdal, Christine, Blix, Hege Salvesen, Plahte, Jens, Røttingen, John-Arne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Health Organization
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328106/ https://www.ncbi.nlm.nih.gov/pubmed/28250535 http://dx.doi.org/10.2471/BLT.16.172874 |
Ejemplares similares
-
The effect of generic market entry on antibiotic prescriptions in the United States
por: Kållberg, Cecilia, et al.
Publicado: (2021) -
Introduction and geographic availability of new antibiotics approved between 1999 and 2014
por: Kållberg, Cecilia, et al.
Publicado: (2018) -
Insights into early stage of antibiotic development in small- and medium-sized enterprises: a survey of targets, costs, and durations
por: Årdal, Christine, et al.
Publicado: (2018) -
An assessment of the future impact of alternative technologies on antibiotics markets
por: Nwokoro, Ejike, et al.
Publicado: (2016) -
Strategies for achieving global collective action on antimicrobial resistance
por: Hoffman, Steven J, et al.
Publicado: (2015)